Royal Bank of Canada’s MGC Diagnostics Corporation MGCD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-557
| Closed | -$6K | – | 7236 |
|
|
2017
Q4 | $6K | Sell |
557
-21,440
| -97% | -$206K | ﹤0.01% | 6058 |
|
|
2017
Q3 | $197K | Buy |
21,997
+11,897
| +118% | +$96.6K | ﹤0.01% | 4533 |
|
|
2017
Q2 | $83K | Hold |
10,100
| – | – | ﹤0.01% | 4866 |
|
|
2017
Q1 | $84K | Hold |
10,100
| – | – | ﹤0.01% | 4861 |
|
|
2016
Q4 | $80K | Hold |
10,100
| – | – | ﹤0.01% | 4997 |
|
|
2016
Q3 | $71K | Hold |
10,100
| – | – | ﹤0.01% | 4990 |
|
|
2016
Q2 | $66K | Sell |
10,100
-1,000
| -9% | -$5.98K | ﹤0.01% | 4988 |
|
|
2016
Q1 | $68K | Buy |
11,100
+4,100
| +59% | +$27K | ﹤0.01% | 4962 |
|
|
2015
Q4 | $46K | Buy |
7,000
+2,000
| +40% | +$13.5K | ﹤0.01% | 5355 |
|
|
2015
Q3 | $33K | Sell |
5,000
-3,500
| -41% | -$19.9K | ﹤0.01% | 5351 |
|
|
2015
Q2 | $48K | Hold |
8,500
| – | – | ﹤0.01% | 5240 |
|
|
2015
Q1 | $61K | Sell |
8,500
-3,000
| -26% | -$20.9K | ﹤0.01% | 4880 |
|
|
2014
Q4 | $74K | Buy |
11,500
+1,500
| +15% | +$9.78K | ﹤0.01% | 4871 |
|
|
2014
Q3 | $66K | Buy |
10,000
+1,990
| +25% | +$15.4K | ﹤0.01% | 4814 |
|
|
2014
Q2 | $66K | Buy |
8,010
+3,500
| +78% | +$34.6K | ﹤0.01% | 4732 |
|
|
2014
Q1 | $51K | Buy |
4,510
+1,510
| +50% | +$17.1K | ﹤0.01% | 4861 |
|
|
2013
Q4 | $38K | Sell |
3,000
-4,000
| -57% | -$48.9K | ﹤0.01% | 5014 |
|
|
2013
Q3 | $77K | Buy |
7,000
+4,000
| +133% | +$35.9K | ﹤0.01% | 4614 |
|
|
2013
Q2 | $25K | Buy |
+3,000
| New | +$21.8K | ﹤0.01% | 4953 |
|
Royal Bank of Canada's MGCD Position: Q1 2018 in Review
Royal Bank of Canada sold out of MGC Diagnostics Corporation (MGCD) in Q1 2018, closing a stake of 557 shares — an estimated $6K sold.
Royal Bank of Canada first reported a position in MGCD in Q2 2013 and held it in 19 quarters. The position peaked at $197K in Q3 2017. 0 funds tracked by Wall St. Rank hold MGCD as of Q1 2018.
- Royal Bank of Canada reported no remaining MGC Diagnostics Corporation position as of Q1 2018 after selling out during the quarter.
- Royal Bank of Canada sold 557 MGC Diagnostics Corporation shares in Q1 2018, an estimated $6K.
- Royal Bank of Canada first reported a position in MGC Diagnostics Corporation in Q2 2013 and held it in 19 quarters.
- Royal Bank of Canada's MGC Diagnostics Corporation position peaked at $197K in Q3 2017.
- 0 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q1 2018.
Based on Royal Bank of Canada's 13F filing for Q1 2018, filed 15 May 2018.